Bioactive Glass (S53P4) as Bone Graft Substitute in Operative Treatment of Depressed Lateral Condyle Fractures, Benign Bone Tumour Cavities and in Spinal Fusion - a 10 Years Follow-up and Bone Density Study.
N/A
N/A
N/A
N/A
N/A
Not Enrolling
Both
Depressed Lateral Condyle Fracture, Benign Bone Tumour Cavity, Spinal Fusion
Both
Depressed Lateral Condyle Fracture, Benign Bone Tumour Cavity, Spinal Fusion
Trial Information
Bioactive Glass (S53P4) as Bone Graft Substitute in Operative Treatment of Depressed Lateral Condyle Fractures, Benign Bone Tumour Cavities and in Spinal Fusion - a 10 Years Follow-up and Bone Density Study.
Inclusion Criteria:
- Written informed consent obtained; Participation of previous clinical investigation
with bioactive glass
Exclusion Criteria:
- The subject is unlikely to adhere to study procedures
- Concurrent disease or condition that in the opinion of the investigator is
contraindicating participation
- Simultaneous participation in another medical device or investigational drug trial
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Cross-Sectional
Principal Investigator
Nina Lindfors, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Turku University Hospital/Helsinki University Hospital
Authority:
Finland: Finnish Medicines Agency
Study ID:
1005-3
NCT ID:
NCT00935870
Start Date:
January 2008
Completion Date:
February 2009
Related Keywords:
- Depressed Lateral Condyle Fracture
- Benign Bone Tumour Cavity
- Spinal Fusion
- Bone Neoplasms
- Fractures, Bone
- Depression
Name | Location |
|---|
